Resistance Studies with Daptomycin
Open Access
- 1 June 2001
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (6), 1799-1802
- https://doi.org/10.1128/aac.45.6.1799-1802.2001
Abstract
We studied the in vitro emergence of resistance to daptomycin using three methods: spontaneous resistance incidence, serial passage in the presence of increasing drug concentrations, and chemical mutagenesis. No spontaneously resistant mutants were obtained for any organism tested (−10 for Staphylococcus aureus, −9 for Staphylococcus epidermidis, −9 for Enterococcus faecalis, −9 for Enterococcus faecium, 12.5 μg/ml) had significant growth defects but did not display phenotypes typical ofS. aureus small colony variants. The voltage component (Δψ) of the bacterial membrane potential was increased in three independent resistant isolates. In vivo data showed that some daptomycin-resistant mutants had lost significant virulence. For other mutants, the degree of in vitro resistance was greater than the change in in vivo susceptibility. These results suggest that infection with some daptomycin-resistant organisms may still be easily treatable.Keywords
This publication has 28 references indexed in Scilit:
- Daptomycin: a novel agent for Gram-positive infectionsExpert Opinion on Investigational Drugs, 1999
- The activity of daptomycin on Enterococcus faecium protoplasts: indirect evidence supporting a novel mode of action on lipoteichoic acid synthesisJournal of Antimicrobial Chemotherapy, 1993
- Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032)Antimicrobial Agents and Chemotherapy, 1990
- Turbidimetric response ofStaphylococcus aureus andEnterococcus faecalis to daptomycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- In vitro selection of bacteria resistant to LY146032, a new cyclic lipopeptideAntimicrobial Agents and Chemotherapy, 1988
- LY146032: activity and resistance development in vitroJournal of Antimicrobial Chemotherapy, 1987
- Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1985
- Membrane potential in anaerobically growing Staphylococcus aureus and its relationship to gentamicin uptakeAntimicrobial Agents and Chemotherapy, 1983
- The energized membrane and cellular autolysis in Bacillus subtilisCell, 1981